Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
Solutions designed to help clinicians reduce administrative burden, improve diagnostic accuracy, and spend more time with patients
BMS is moving beyond conversational AI into what it describes as “agentic” systems
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
Dr. Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments
The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
Subscribe To Our Newsletter & Stay Updated